Single answer
Is Assembly Biosciences Inc (ASMB) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Assembly Biosciences Inc is $39.00, which is $6.87 (21.38%) above the current price today's price.
Low target: $38.00 | High target: $40.00
Company snapshot
A quick overview of the business and its public profile.
Assembly Biosciences Inc a clinicalstage biotechnology company discovers and develops therapeutic candidates for the treatment of hepatitis B virus HBV infection in the United States The companys lead product candidate is Vebicorvir which as completed Phase 2 clinical trials to treat patients with chronic HBV infection It is also developing ABIH3733 that has completed Phase 1a clinical study and ABI4334 which is in preclinical trials for the treatment of HBV The company has collaboration agreements with BeiGene Ltd and Arbutus Biopharma Corporation and Antios Therapeutics Inc to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection It also has strategic license agreements with Indiana University Research and Technology Corporation and Door Pharmaceuticals LLC The company was formerly known as Ventrus Biosciences Inc and changed its name to Assembly Biosciences Inc in June 2014 Assembly Biosciences Inc was incorporated in 2005 and is headquartered in South San Francisco California
Website: https://www.assemblybio.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.04. Cash flow to debt ratio: -19.36. Net profit margin: -164.96%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Assembly Biosciences Inc is $4.4M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Assembly Biosciences Inc, 2015-12-31 had a stock price of $90.12. If you invested back then, your return now would be a loss of $57.99 per share or 64.35%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.